Pan-cancer polygenic risk score associates with cancer susceptibility following kidney transplantation
Open Access
- 23 April 2026
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (11)
Abstract
BACKGROUND: Cancer accounts for over 20% of late posttransplant mortality, yet the contribution of genetic susceptibility to posttransplant cancer risk remains unclear. This study investigates germline genetic risk factors for posttransplant cancer in the Finnish population using data from the FinnGen cohort. METHODS: A pan-cancer polygenic risk score (PRS) was constructed using genetic variants identified in UK and US populations to assess the influence of common germline variants on time to first cancer diagnosis in 1,802 Finnish kidney transplant recipients (KTRs), of whom 317 developed posttransplant cancer. The PRS was first validated in the FinnGen non-transplantation cohort and subsequently applied to KTRs, with replication in lung and liver transplant recipients ( n = 476). Functional relevance was explored by assessing associations between the PRS and expression levels of 2,923 plasma proteins in the UK Biobank ( n = 53,013). RESULTS: Compared with a matched non-transplantation cohort ( n = 68,294), KTRs exhibited earlier cancer onset. The PRS was significantly associated with time to first cancer diagnosis in the non-transplantation population (HR 1.04, 95% CI 1.038–1.056, P = 3.75 × 10 –25 ). Among KTRs younger than 40 years, higher PRS was associated with earlier cancer onset (HR 1.08, 95% CI 1.01–1.17, P = 0.036), indicating a stronger genetic effect at younger ages. The PRS significantly (Bonferroni < 0.05) altered the regulation of 87 plasma proteins, several of which were known cancer-related markers. CONCLUSION: Inherited genetic predisposition, captured by pan-cancer PRS, may contribute to individual susceptibility to cancer after solid organ transplantation, particularly at younger ages. FUNDING: State research funding (Helsinki and Uusimaa Health District), the Foundation for Pediatric Research, and the Sigrid Jusèlius Foundation.Keywords
Funding Information
- Lastentautien Tutkimussäätiö (Number not available)
This publication has 52 references indexed in Scilit:
- Immunosuppression and cancer risk in kidney transplant recipients: A retrospective cohort studyInternational Journal of Cancer, 2024
- Cancer risk and mortality after solid organ transplantation: A population‐based 30‐year cohort study in FinlandInternational Journal of Cancer, 2022
- Generalizability of Polygenic Risk Scores for Breast Cancer Among Women With European, African, and Latinx AncestryJAMA Network Open, 2021
- Cancer morbidity and mortality after pediatric solid organ transplantation—a nationwide register studyPediatric Nephrology, 2020
- Cumulative incidence of cancer after solid organ transplantationCancer, 2013
- Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008—A Swedish population‐based studyInternational Journal of Cancer, 2012
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJAMA, 2011
- Cancer incidence and risk factors after solid organ transplantationInternational Journal of Cancer, 2009
- Cancer Incidence Before and After Kidney TransplantationJAMA, 2006
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002